$0.684900
-0.01-1.74%
Pre-Market: 6:52 PM EDT
15 minutes delayed
Comments
Loading...
Cyclo Therapeutics (CYTH) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCyclo Therapeutics (NASDAQ:CYTH) Stock Quotes, Forecast and News Summary
Cyclo Therapeutics Stock (NASDAQ: CYTH) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 76.18K |
| Day Range | - - - |
| 52 Wk Range | 0.59 - 2.12 |
| Market Cap | $19.65M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 35 |
| Short Interest | 0.81% |
| Days to Cover | 1.83 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cyclo Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cyclo Therapeutics (CYTH) stock?
You can purchase shares of Cyclo Therapeutics (NASDAQ:CYTH) through any online brokerage.
Who are Cyclo Therapeutics (CYTH) competitors?
Other companies in Cyclo Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX) and Palatin Techs (AMEX:PTN).
What is the forecast, or price target, for Cyclo Therapeutics (CYTH) stock?
Cyclo Therapeutics has a consensus price target of $0.95.
What is the current price for Cyclo Therapeutics (CYTH)?
The stock price for Cyclo Therapeutics (NASDAQ: CYTH) is $0.6849 last updated September 23, 2024 at 6:52 PM EDT.
Does Cyclo Therapeutics (CYTH) pay a dividend?
There are no upcoming dividends for Cyclo Therapeutics.
When is Cyclo Therapeutics (NASDAQ:CYTH) reporting earnings?
Cyclo Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Cyclo Therapeutics (CYTH) going to split?
There is no upcoming split for Cyclo Therapeutics.
What sector and industry does Cyclo Therapeutics (CYTH) operate in?
Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.